Received Oct 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
MA gave the vaccine yesterday to a fifteen months old child, the Infanrix and it expired July thirteenth of twenty twenty-five; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired drug administered in a 15-month-old patient who received DTPa (Infanrix) (expiry date 13-JUL-2025) for prophylaxis. The patient experienced expired drug administered (Verbatim: MA gave the vaccine yesterday to a fifteen months old child, the Infanrix and it expired July thirteenth of twenty twenty-five). The outcome of the expired drug administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-SEP-2025 The clinic coordinator reported that, a medical assistant gave the vaccine a day before day of reporting to a fifteen-month-old child, the Infanrix and it expired 13th July 2025. The healthcare professional did not have the lot number or the patient information.